Crucially, the CUA+ cohort, specifically in the absence of tau pathology (T−) or neurodegeneration (N−), aligns with the earliest conceptualization of the AD continuum, potentially capturing individuals decades before clinical onset. This evidence concerns the gene MAPT and Alzheimer disease.